ADVFN US – Market Content Editor

Telix Pharmaceuticals Ltd ADR (NASDAQ:TLX) saw its stock plummet 19% in premarket trading Thursday following the announcement that the U.S. Food and Drug Administration issued a Complete Response Letter (CRL) for its investigational PET imaging agent, TLX250-CDx. The FDA highlighted issues in the Chemistry, Manufacturing, and Controls (CMC) section of the TLX250-CDx (Zircaix) application, which…

Malibu Boats, Inc. (NASDAQ:MBUU) saw its shares drop 6.38% in pre-market trading Thursday after reporting strong fourth-quarter results but providing a conservative outlook for fiscal 2026. The recreational boatmaker posted Q4 net sales of $207 million, a 30.4% increase from a year ago, well above analyst expectations of $178.2 million. Adjusted earnings per share came…

Lucky Strike Entertainment (NYSE:LUCK) shares edged higher by 1.87% in pre-market trading Thursday after the location-based entertainment company reported fourth-quarter revenue that surpassed analyst forecasts. For its fourth quarter of fiscal 2025, Lucky Strike posted total revenue of $301.2 million, beating expectations of $292.61 million and reflecting a 6.1% increase from the same period last…

Redwire Corporation (NYSE:RDW) shares climbed 5% after the space technology company secured a $25 million single-award indefinite-delivery/indefinite-quantity (IDIQ) contract from NASA. The deal tasks Redwire with providing biotechnology facilities and supporting on-orbit operations aboard the International Space Station (ISS). The five-year agreement allows Redwire to fulfill future task orders related to biotechnology facilities, mission integration,…

Ollie’s Bargain Outlet Holdings, Inc. (NASDAQ:OLLI) saw its stock jump 4.1% following the release of second-quarter results that exceeded analyst expectations, accompanied by an upgraded full-year forecast. The discount retailer reported adjusted earnings per share of $0.99, surpassing the consensus estimate of $0.93. Revenue totaled $679.56 million, above the anticipated $662.22 million, marking a 17.5%…

CEL-SCI Corporation (AMEX:CVM) saw its stock drop 31% following the announcement of a $10 million public offering priced well below its prior closing value. The clinical-stage cancer immunotherapy company set a best-efforts public offering of 1,111,200 common shares at $9.00 each, a 31% discount to Wednesday’s closing price of $13.04. The offering is expected to…

Shares of Cognition Therapeutics Inc. (NASDAQ:CGTX) declined 17% after the clinical-stage biotech company announced a $30 million registered direct offering of common stock. The offering includes the sale of 14,700,000 shares to two new institutional investors, one of which the company described as a “preeminent global investment manager.” The transaction is expected to close around…

Accelerant Holdings (NYSE:ARX), the tech company operating a data-driven risk exchange platform for the specialty insurance sector, saw its shares climb 2.15% in pre-market trading on Thursday after reporting second-quarter results that surpassed analyst expectations. The company posted adjusted earnings of $0.04 per share for the quarter ending June 30, 2025, alongside revenue of $219.1…

Best Buy (NYSE:BBY) reported second-quarter results that exceeded analyst projections, while reaffirming its full-year guidance amid ongoing uncertainty over tariffs. Despite the positive numbers, the retailer’s shares dipped more than 1% in pre-market trading on Thursday. The company posted earnings per share (EPS) of $1.28, beating the consensus estimate of $1.22, with revenue reaching $9.44…

Outlook Therapeutics (NASDAQ:OTLK) stock fell sharply, tumbling 70% in pre-market trading Thursday following the U.S. Food and Drug Administration’s (FDA) rejection of its ONS-5010/LYTENAVA (bevacizumab-vikg) application, intended as a treatment for wet age-related macular degeneration (wet AMD). The FDA issued a Complete Response Letter (CRL) for the company’s resubmitted Biologics License Application (BLA), citing a…